Medicine & Life Sciences
Breast Neoplasms
100%
Neoplasms
53%
Medicare
42%
Survival
39%
Costs and Cost Analysis
31%
Early Detection of Cancer
31%
Drug Therapy
29%
Decision Support Techniques
28%
Radiotherapy
27%
Therapeutics
27%
Lung Neoplasms
24%
Guidelines
22%
Cost-Benefit Analysis
21%
Confidence Intervals
20%
Breast
20%
Systematic Reviews
17%
Prostatic Neoplasms
17%
Radiation
15%
Cancer Survivors
15%
Population
14%
Shared Decision Making
14%
Databases
14%
Randomized Controlled Trials
14%
Odds Ratio
14%
Colorectal Neoplasms
13%
Epidemiology
13%
Male Breast Neoplasms
13%
Adjuvant Chemotherapy
13%
Elderly
12%
Rectal Neoplasms
12%
Decision Making
11%
Mastectomy
11%
Recurrence
11%
Segmental Mastectomy
11%
Registries
10%
Mortality
10%
Hispanic Americans
10%
Logistic Models
10%
Health
10%
Ovarian Neoplasms
10%
Smoking Cessation
10%
Incidence
10%
Practice Guidelines
9%
human ERBB2 protein
9%
Medication Therapy Management
9%
Trastuzumab
9%
Quality-Adjusted Life Years
9%
Health Expenditures
9%
Meta-Analysis
9%
Quality of Life
9%
Head and Neck Neoplasms
9%
Physicians
8%
Hormones
8%
European Continental Ancestry Group
8%
Insurance
8%
Oncologists
8%
Economics
8%
Survivorship
8%
Rheumatoid Arthritis
8%
Carcinoma, Intraductal, Noninfiltrating
8%
Comorbidity
7%
Mammaplasty
7%
Medical Oncology
7%
Clinical Trials
7%
Uterine Cervical Neoplasms
7%
Delivery of Health Care
7%
Cohort Studies
7%
Prophylactic Mastectomy
6%
Mammography
6%
Practice Management
6%
Watchful Waiting
6%
Neoplasm Metastasis
6%
Health Care Costs
6%
Colonic Neoplasms
6%
Hospitalization
6%
Melanoma
6%
Triple Negative Breast Neoplasms
6%
African Continental Ancestry Group
6%
Patient Reported Outcome Measures
6%
Estrogen Receptors
6%
Patient Protection and Affordable Care Act
6%
Immunotherapy
6%
Non-Small Cell Lung Carcinoma
5%
Proportional Hazards Models
5%
Brachytherapy
5%
Genotype
5%
Survivors
5%
Smokers
5%
Neuroendocrine Tumors
5%
Smoking
5%
Propensity Score
5%
Tomography
5%
Interviews
5%
Medicaid
5%
Pancreatic Neoplasms
5%
Squamous Cell Carcinoma of Head and Neck
5%
Observational Studies
5%
Medicare Part D
5%